A total of 49 anaerobic and 52 aerobic or facultative bacteria were tested for their susceptibilities to clindamycin and ceftazidime alone and in combination. Synergy was noted for 11 strains, whereas antagonism was not detected. The combination of clindamycin and ceftazidime may prove to be useful for the treatment of severe mixed infections caused by anaerobes and aerobes or facultative bacteria. (9); other bacteria were identified by the criteria outlined in the Manual of Clinical Microbiology (6). All isolates had been stored in vials of skim milk frozen at -70°C.
Bacterial infections that arise from the flora of the oropharynx, female genital tract, or distal bowel are often polymicrobial and include both anaerobic and nonanaerobic microorganisms. Although a variety of antimicrobial agents may often be effective for treatment of such infections, many experts recommend that initial, empirical treatment of severe infections include the use of an aminoglycoside for coverage of the facultative and aerobic gram-negative bacilli and the use of another agent, such as cefoxitin, chloramphenicol, clindamycin, metronidazole, or ticarcillin, for coverage of anaerobic bacteria (2, 4, 11) . Each of these regimens includes an aminoglycoside and therefore carries the risk of oto-and nephrotoxicity and also necessitates measurement of drug levels in serum, frequent serum creatinine determinations, and audiometric evaluation.
We considered the potential utility of various combinations of agents that might be used for the treatment of mixed or polymicrobial infections. One such combination is clindamycin, which has excellent activity versus anaerobic bacteria (10) , plus ceftazidime, which has excellent activity versus facultative and aerobic gram-negative bacilli (8) (9); other bacteria were identified by the criteria outlined in the Manual of Clinical Microbiology (6). All isolates had been stored in vials of skim milk frozen at -70°C.
Brucella broth supplemented with hemin and vitamin K1 (9) was used to prepare a working solution that contained 8 pLg of clindamycin per ml and a working solution that contained 128 ,ug of ceftazidime per ml. These broths were then diluted, and the dilutions were combined with each dilution of the other drug or with antibiotic-free broth to yield a checkerboard array of doubling dilutions of clindamycin from 4 to 0.063 ,ug/ml and of ceftazidime from 64 to 0.063 pug/ml. This arrangement permitted determination of the MICs of clindamycin and ceftazidime for each isolate and assessment of the activity of all 7 concentrations of clindamycin in combination with each of the 11 concentrations of ceftazidime. These combinations were then dispensed into 96-well U-bottomed microtiter trays (Dynatech Laboratories, Inc., Alexandria, Va.) with a 96-channel semiautomatic dispenser (MIC 2000; Dynatech Corp.) set to dispense 100 ,ul per well. The trays were sealed with sterile tape and kept frozen at -70°C until use.
All isolates were passaged on blood agar three times before study. Five colonies of each of the aerobic and facultatively anaerobic bacteria were inoculated into 10 ml of thioglycolate 135C broth (BBL Microbiology Systems, Cockeysville, Md.), incubated at 37?C for 4 to 6 h, and then diluted to the density of a McFarland no. 1 standard in 4 ml of brucella broth; this broth was then diluted 10-fold in brucella broth supplemented with vitamin K1 and hemin. Anaerobic bacteria were prepared for testing by first inoculating five colonies of each strain into a tube containing 4.5 ml of reduced, concentrated thioglycolate 135C broth (15 g of thioglycolate powder plus 417 ml of distilled water supplemented with hemin, vitamin Kl, and sodium bicarbonate [9] ) to which 0.5 ml of peptic digest of sheep blood (Fildes enrichment) had been added. Rapid growers were incubated anaerobically for 4 to 6 h, and slow growers were incubated overnight. The culture was then diluted to a McFarland no. 1 standard in unsupplemented brucella broth, which was then diluted 10-fold in brucella broth supplemented with hemin and vitamin K1. Broth culture of the one strain of Bacteroides ureolyticus tested was supplemented with formatefumarate throughout to enhance growth (9) .
Wells were inoculated by use of a multipoint replicator inoculator (Dynatech Laboratories) to transfer 0.0015 ml of bacterial suspension to each of the 96 antibiotic-containing wells. This produced a final concentration of bacteria of ca. 5
x 105 cells per ml. The trays were then incubated in an appropriate atmosphere; anaerobic bacteria were incubated for 48 h and other bacteria were incubated for 24 h. After incubation, the microtiter trays were read with an illuminated magnifying reader (Dynatech Laboratories). Growth was considered to be present whenever visible turbidity was detected.
Synergy was defined as a reduction in MICs of both drugs in combination of fourfold or greater and antagonism as an increase in MICs of both drugs in combination of fourfold or greater (Table 1) . Antagonism was not detected. Synergy occurred with 11 strains (mostly anaerobic bacteria) and was ANTIMICROB. AGENTS CHEMOTHER. 
